Department of Medicine and Surgery, Università di Parma, Parma, Italy.
Azienda Ospedaliero-Universitaria di Parma, Parma, Italy.
Diabetes Metab Res Rev. 2020 Nov;36(8):e3347. doi: 10.1002/dmrr.3347. Epub 2020 Jun 25.
To build a tool to assess the management of inpatients with diabetes mellitus and to investigate its relationship, if any, with clinical outcomes.
A total of 678 patients from different settings, Internal Medicine (IMU, n = 255), General Surgery (GSU, n = 230) and Intensive Care (ICU, n = 193) Units, were enrolled. A work-flow of clinical care of diabetes was created according to guidelines. The workflow was divided into five different domains: (a) initial assessment; (b) glucose monitoring; (c) medical therapy; (d) consultancies; (e) discharge. Each domain was assessed by a performance score (PS), computed as the sum of the scores achieved in a set of indicators of clinical appropriateness, management and patient empowerment. Appropriate glucose goals were included as intermediate phenotypes. Clinical outcomes included: hypoglycaemia, survival rate and clinical conditions at discharge.
The total PS and those of initial assessment and glucose monitoring were significantly lower in GSU with respect to IMU and ICU (P < .0001). The glucose monitoring PS was associated with lower risk of hypoglycaemia (OR = 0.55; P < .0001), whereas both the PSs of glucose monitoring and medical therapy resulted associated with higher in-hospital survival only in the IMU ward (OR = 6.67 P = .001 and OR = 2.38 P = .03, respectively). Instrumental variable analysis with the aid of PS of glucose monitoring showed that hypoglycaemia may play a causal role in in-hospital mortality (P = .04).
The quality of in-hospital care of diabetes may affect patient outcomes, including glucose control and the risk of hypoglycaemia, and through the latter it may influence the risk of in-hospital mortality.
建立一种评估住院糖尿病患者管理的工具,并研究其与临床结局的关系。
共纳入来自不同科室的 678 例患者,内科(IMU,n=255)、普通外科(GSU,n=230)和重症监护(ICU,n=193)。根据指南制定了糖尿病临床护理工作流程。该工作流程分为五个不同领域:(a)初始评估;(b)血糖监测;(c)药物治疗;(d)会诊;(e)出院。每个领域的表现评分(PS)通过一系列临床适宜性、管理和患者授权的指标得分之和来评估。适当的血糖目标被纳入中间表型。临床结局包括:低血糖、生存率和出院时的临床状况。
与 IMU 和 ICU 相比,GSU 的总 PS 以及初始评估和血糖监测 PS 显著较低(P<0.0001)。血糖监测 PS 与低血糖风险降低相关(OR=0.55;P<0.0001),而血糖监测和药物治疗 PS 仅与 IMU 病房的住院生存率相关(OR=6.67,P=0.001 和 OR=2.38,P=0.03)。借助血糖监测 PS 的工具变量分析表明,低血糖可能在住院死亡率中起因果作用(P=0.04)。
住院糖尿病患者的治疗质量可能会影响患者的结局,包括血糖控制和低血糖风险,而后者可能会影响住院死亡率。